Maravai Lifesciences Holdings Inc. (MRVI)
NASDAQ · Healthcare
Maravai Lifesciences Holdings Inc. Shareholder Equity 2020–2025
Maravai Lifesciences Holdings Inc. annual shareholder equity history from 2020 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Maravai Lifesciences Holdings Inc. shareholder equity as of December 31, 2025: 372.7M, a 35.43% decrease year-over-year.
- Maravai Lifesciences Holdings Inc. shareholder equity for 2025 were 372.7M, a 35.43% decrease from 2024.
- Maravai Lifesciences Holdings Inc. shareholder equity for 2024 were 577.2M, a 26.92% decrease from 2023.
- Maravai Lifesciences Holdings Inc. shareholder equity for 2023 were 789.9M, a 12.74% decrease from 2022.
- Maravai Lifesciences Holdings Inc. shareholder equity for 2022 were 905.2M.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Maravai Lifesciences Holdings Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $373 |
| 2024 | $577 |
| 2023 | $790 |
| 2022 | $905 |
| 2021 | $545 |
| 2020 | $155 |
Maravai Lifesciences Holdings Inc. Shareholder Equity — FAQ
Maravai Lifesciences Holdings Inc. (MRVI) shareholder equity over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see MRVI's shareholder equity history?
The chart and table above show Maravai Lifesciences Holdings Inc.'s shareholder equity by year and by quarter, including the growth rate.